Cell therapy in amyotrophic lateral sclerosis: Science and controversy;Terapia celular en la esclerosis lateral amiotrófica: Ciencia y controversia

Neurologia

Volumn 25, Issue 8, 2010, Pages 467-469

  Galan L ^a   Guerrero Sola, A ^a   Gomez Pinedo U ^b   Matias Guiu, J ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

Author keywords

Amyotrophic lateral sclerosis; Cell therapy; Neurodegenerative disease; Stem cells

Indexed keywords

ADIPOCYTE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BONE MARROW CELL; CLINICAL PRACTICE; DEGENERATIVE DISEASE; HUMAN; STEM CELL TRANSPLANTATION; TOOTH PULP;

AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL TRIALS AS TOPIC; HUMANS; NEURODEGENERATIVE DISEASES; STEM CELL TRANSPLANTATION; TISSUE THERAPY;

EID: 77958102044     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2010.07.016     Document Type: Article

References (23)

1. Bensimon G., Lacomblez L., Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med. 1994, 330:585-591.
2. Lindvall O., Kokaia Z. Stem cells in human neurodegenerative disorders--time for clinical translation?. J Clin Invest. 2010, 120:29-40.
3. Matias-Guiu J., Barcia J.A., García-Verdugo J.M., Galán L., Vela A., García-Ramos R. Terapia celular en la Esclerosis Lateral Amiotrófica. Neurologia. 2008, 23:226-237.
4. Papadeas S.T., Maragakis N.J. Advances in stem cell research for amyotrophic lateral sclerosis. Curr Opin Biotechnol. 2009, 20(5):545-551.
5. Amariglio N., Hirshberg A., Scheithauer B.W., Cohen Y., Loewenthal R., Trakhtenbrot L., et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 2009, 6:e1000029.
6. Appel S.H., Engelhardt J.I., Henkel J.S., Siklos L., Beers D.R., Yen A.A., et al. Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis. Neurology. 2008, 71:1326-1334.
7. Martínez H.R., González-Garza M.T., Moreno-Cuevas J.E., Caro E., Gutiérrez-Jiménez E., Segura J.J. Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients. Cytotherapy. 2009, 11:26-34.
8. Mazzini L., Mareschi K., Ferrero I., Vassallo E., Oliveri G., Nasuelli N., et al. Stem cell treatment in amyotrophic lateral sclerosis. J Neurol Sci. 2008, 265:78-83.
9. Deda H., Inci M.C., Kurekci A.E., Sav A., Kayihan K., Ozgun E., et al. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy. 2009, 11:18-25.
10. Mitchell J.D., Borasio G.D. Amyotrophic lateral sclerosis. Lancet. 2007, 369:2031-2041.
11. Boillee S., Vande Velde C., Cleveland D.W. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron. 2006, 52:39-59.
12. Ravits J.M., La Spada A.R. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology. 2009, 73:805-811.
13. Gao J., Coggeshall R.E., Tarasenko Y.I., Wu P. Human neural stem cell-derived cholinergic neurons innervate muscle in motoneuron deficient adult rats. Neuroscience. 2005, 131:257-262.
14. Wichterle H., Lieberam I., Porter J.A., Jessell T.M. Directed differentiation of embryonic stem cells into motor neurons. Cell. 2002, 110:385-397.
15. Lepore A.C., Rauck B., Dejea C., Pardo A.C., Rao M.S., Rothstein J.D., et al. Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci. 2008, 11:1294-1301.
16. Suzuki M., McHugh J., Tork C., Shelley B., Klein S.M., Aebischer P., et al. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS One. 2007, 2:e689.
17. Suzuki M., McHugh J., Tork C., Shelley B., Hayes A., Bellantuono I., et al. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Mol Ther. 2008, 16:2002-2010.
18. Vercelli A., Mereuta O.M., Garbossa D., Muraca G., Mareschi K., Rustichelli D., et al. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis. 2008, 31:395-405.
19. Garbuzova-Davis S., Sanberg C.D., Kuzmin-Nichols N., Willing A.E., Gemma C., Bickford P.C., et al. Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose. PLoS One. 2008, 3:e2494.
20. Beers D.R., Henkel J.S., Zhao W., Wang J., Appel S.H. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc Natl Acad Sci U S A. 2008, 105:15558-15563.
21. Badayan I., Cudkowicz M.E. Is it too soon for mesenchymal stem cell trials in people with ALS? Amyotroph Lateral Scler. 2008, 9:321-322.
22. Lau D., Ogbogu U., Taylor B., Stafinski T., Menon D., Caulfield T. Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine. Cell Stem Cell. 2008, 3:591-594.
23. Hyun I., Lindvall O., Ahrlund-Richter L., Cattaneo E., Cavazzana-Calvo M., Cossu G., et al. New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell. 2008, 3:607-609.